I agree,... too bad we are not already on the Nasdaq or maybe hopefully plan to be so. Biogen's market cap went up more than $10 billion USD when they announced Phase 2 results for their alzhiemer's drug,... 

Our sub-group study is bigger and it went longer than their phase 2 trial,... and watch when we announce better results,... maybe we will gain $200 million on our market cap.

We need the Nasdaq arena,... it will get the price up and lit a fire under the seat of the BP's to start moving on us.